Merging microfluidics with luminescence immunoassays for urgent point-of-care diagnostics of COVID-19
{{output}}
The Coronavirus disease 2019 (COVID-19) outbreak has urged the establishment of a global-wide rapid diagnostic system. Current widely-used tests for COVID-19 include nucleic acid assays, immunoassays, and radiological imaging. Immunoassays play an irreplaceabl... ...
